RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.67B
AUM Growth
-$1.54B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$82.4M
2
+$55.9M
3
+$47.2M
4
RLMD icon
Relmada Therapeutics
RLMD
+$45.1M
5
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
+$34.8M

Top Sells

1
+$190M
2
+$35.9M
3
+$21M
4
CTMX icon
CytomX Therapeutics
CTMX
+$17.8M
5
WHWK
Whitehawk Therapeutics
WHWK
+$10.2M

Sector Composition

1 Healthcare 98.88%
2 Financials 0.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$11.7M 0.21%
118,916
77
$11.6M 0.21%
5,600,000
+3,968,365
78
$11.6M 0.2%
1,742,186
79
$11.4M 0.2%
310,284
-570,000
80
$10.1M 0.18%
423,616
81
$10.1M 0.18%
750,000
82
$9.92M 0.17%
1,000,000
83
$9.7M 0.17%
1,000,000
84
$9.56M 0.17%
3,033,603
85
$9.4M 0.17%
62,500
86
$8.8M 0.16%
1,025,641
87
$7.44M 0.13%
2,850,000
88
$7.39M 0.13%
750,000
89
$6.8M 0.12%
1,262,193
90
$6.62M 0.12%
2,353,000
91
$6.3M 0.11%
625,000
92
$5.86M 0.1%
+1,849,518
93
$5.65M 0.1%
1,255,317
94
$5.4M 0.1%
350,000
95
$3.73M 0.07%
500,000
96
$3.36M 0.06%
275,000
97
$2.93M 0.05%
90,000
98
– –
-5,427,655
99
– –
-3,500,000
100
– –
-700,000
1 2 3
4
5